0001399529-21-000062.txt : 20210405 0001399529-21-000062.hdr.sgml : 20210405 20210405213657 ACCESSION NUMBER: 0001399529-21-000062 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210203 FILED AS OF DATE: 20210405 DATE AS OF CHANGE: 20210405 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brown Bob D CENTRAL INDEX KEY: 0001598479 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36281 FILM NUMBER: 21807955 MAIL ADDRESS: STREET 1: 87 CAMBRIDGEPARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 FORMER NAME: FORMER CONFORMED NAME: Brown Bob DATE OF NAME CHANGE: 20140129 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Dicerna Pharmaceuticals Inc CENTRAL INDEX KEY: 0001399529 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 205993609 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 75 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 617 621 8097 MAIL ADDRESS: STREET 1: 75 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 4/A 1 wf-form4a_161767292102255.xml FORM 4/A X0306 4/A 2021-02-03 2021-02-04 0 0001399529 Dicerna Pharmaceuticals Inc DRNA 0001598479 Brown Bob D C/O DICERNA PHARMACEUTICALS, INC. 75 HAYDEN AVENUE LEXINGTON MA 02421 0 1 0 0 Chief Scientific Ofr., EVP R&D Common Stock 2021-02-03 4 M 0 3066 3.42 A 24583 D Common Stock 2021-02-03 4 M 0 5246 2.97 A 29829 D Employee Stock Option (Right to Buy) 3.42 2021-02-03 4 M 0 3066 0 D 2023-09-24 Common Stock 3066.0 74808 D Employee Stock Option (Right to Buy) 2.97 2021-02-03 4 M 0 5246 0 D 2027-01-03 Common Stock 5246.0 0 D The Reporting Person's original Form 4 as filed with the Securities and Exchange Commission on February 4, 2021 (the "Original Form 4") is hereby amended to reflect the correct option grants from which the shares were exercised. The aggregate total number of shares exercised (8,312 shares) was correctly reported in the Original Form 4. Except as noted in this amended Form 4, all other information disclosed in the Original Form 4 was accurately reported and remains unchanged. As of the transaction date, the option was fully vested. The option vested 1/48 monthly on the last day of each month with the vesting start date of 7/30/2013. The option vests in 48 monthly installments over the four-year period starting on the last day of January 2017, subject in each case to the Reporting Person's continued service with the Issuer through the applicable vesting date. /s/ Douglas W. Pagan, attorney-in-fact 2021-04-05